[Remote] EMR Integrations Manager at BillionToOne

Remote

BillionToOne Logo
Not SpecifiedCompensation
N/AExperience Level
N/AJob Type
Not SpecifiedVisa
N/AIndustries

Requirements

  • Bachelor’s degree in Health Informatics, Information Systems, or related field preferred
  • 5+ years of experience in lab systems, EMR integration, interoperability, or healthcare IT
  • Understanding of HL7 integrations, interoperability, and vendor connectivity
  • Excellent project management skills
  • Excellent stakeholder coordination and communication skills

Responsibilities

  • Manage day-to-day EMR integration operations, ensuring accurate and timely order and result transmissions
  • Oversee HL7 integrations, including setup, validation, testing, and ongoing monitoring
  • Lead manual EMR order associations and triage, investigating and resolving missing or misrouted orders and results
  • Improve and maintain automation processes for EMR order matching
  • Coordinate manual testing workloads for EMR integrations
  • Serve as the project manager for EMR integrations across all business units
  • Manage the intake and approval process for new EMR integration requests
  • Represent EMR Operations on hospital and clinic integration calls
  • Collaborate with Engineering and Product teams to resolve issues and drive continuous improvement
  • Lead triage of EMR order management issues
  • Coordinate with Engineering, Account Executives, and vendors to investigate and implement corrective actions
  • Manage the EMR Slack triage channel
  • Partner with Sales to manage client onboarding workflows
  • Act as the central point of communication between IT, Engineering, Sales, Legal, and Clinical Operations for all EMR-related processes
  • Maintain and improve internal documentation and playbooks for EMR operations and troubleshooting

Skills

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$380.2MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Competitive pay
Retirement savings package
Parental leave
Free snacks & lunches
Medical, dental, & vision premiums
On campus perks
Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.
Rapid technological advancements may render their current technology obsolete.
Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.
Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.
They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.
Their new Austin facility will create 1,000 jobs, boosting production and local economy.
Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI